It is therefore vital for tumour cells to tightly regulate IFN signalling to survive treatment, which is plausibly mediated through the attenuation of ISGs by SETDB1/2 following an initial burst of inflammation and dedifferentiation that promotes their activation. Here, IFNA1 is linked to neoplasm.